Finnish Researchers Discover Genes Inhibiting the Spread of Prostate Cancer
News May 15, 2012
The research team of Professor Johanna Ivaska (University of Turku and VTT Technical Research Centre of Finland) screened dozens of prostate cancers using gene silencing and discovered mechanisms of that inhibit the spread of cancer cells.
Published in the Journal of Cell Science, the study shows that cancer cell adhesive activity, which is easy to measure in a laboratory setting, is directly linked to the ability of the cancer cells to metastasize.
As a result, screening for regulators of cancer cell activity can lead to the discovery of new candidates for pharmaceutical development.
The study describes dozens of new regulators of cancer cell activity; employing gene silencing mechanisms on two of these regulators (CD9 and MMP8) was found to have a direct impact on the spreading of cancer cells.
In the study, researchers Teijo Pellinen and Juha Rantala from Professor Ivaska's research team utilized the cell spot micro array technology developed by VTT.
The method allows researches to study the impacts of all genes in an entire genome in a single experiment.
The study was published in the Journal of Cell Science, a distinguished publication in the field of cell biology.
Phenogenetic Map Created For Stem Cell Models Of Neurological DiseasesNews
Researchers at The Ohio State University Wexner Medical Center have performed the first meta-analysis of all induced pluripotent stem cell models for neurological and neurodegenerative diseases, and created an atlas of how cell characteristics are linked to their genotype.READ MORE
Fabric Genomics Partners to Improve Pediatric CareNews
Partnerships with Genomics England, Rady Children's Institute for Genomic Medicine, and The Utah Genome Project demonstrate diagnostic utility of Fabric Genomics' algorithm-based genome analysis.READ MORE
Key Cancer-Linked Proteins Thought to be ‘Undruggable’ Until NowNews
A new study published in Nature, conducted by an alliance between industry and academia involving the University of Liverpool, highlights a new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’.READ MORE